PUBLICACIONES MÁS RELEVANTES EN LOS ÚLTIMOS 5 AÑOS
|
|
|
|
|
|
|
|
|
|
|
|
Fernández-Rodríguez S, Esposito-Zapero C, Zornoza T, Polache A, Granero L, Cano-Cebrián MJ. The Effects of N-Acetylcysteine on the Rat Mesocorticolimbic Pathway: Role of mGluR5 Receptors and Interaction with Ethanol. Pharmaceuticals. 2021 Jun; 14(6):593. doi:10.3390/ph14060593 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cano-Cebrián MJ, Fernández-Rodríguez S, Hipólito L, Granero L, Polache A, Zornoza T. Efficcacy of N-acetylcysteine in the prevention of alcohol relapse-like drinking: Study in long-term ethanol-experienced male rats. J Neurosci Res. 2021 Feb;99(2):638-648. doi: 10.1002/jnr.24736. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Esposito-Zapero C, Fernández-Rodríguez S, Sánchez-Catalán MJ, Zornoza T, Cano-Cebrián MJ, Granero L. The rostromedial tegmental nucleus RMTg is not a critical site for ethanol-induced motor activation in rats. Psychopharmacology (Berl). 2023 Oct;240(10):2071-2080. doi: 10.1007/s00213-023-06425-4. Epub 2023 Jul 20. PMID: 37474756; PMCID: PMC10506920. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fernández-Rodríguez S, Cano-Cebrián MJ, Esposito-Zapero C, Pérez S, Guerri C, Zornoza T, Polache A. N-Acetylcysteine normalizes brain oxidative stress and neuroinflammation observed after protracted ethanol abstinence: a preclinical study in long-term ethanol-experienced male rats. Psychopharmacology (Berl). 2023 Apr;240(4):725-738. doi: 10.1007/s00213-023-06311-z. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fernández-Rodríguez S, Cano-Cebrián MJ, Rius-Pérez S, Pérez S, Guerri C, Granero L, Zornoza T, Polache A. Different brain oxidative and neuroinflammation status in rats during prolonged abstinence depending on their ethanol relapse-like drinking behavior: Effects of ethanol reintroduction. Drug Alcohol Depend. 2022 Mar 1;232:109284. doi: 10.1016/j.drugalcdep.2022.109284. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|